Kim JG, et al. - In patients with indistinguishable T2/T3-N0 rectal cancer on rectal magnetic resonance imaging (MRI), researchers compared the outcome between surgery-first and neoadjuvant chemoradiation therapy (nCRT)-first strategies. Among 1,910 subjects who had rectal MRI between 2008 and 2012, 79 subjects who had indistinguishable T2/T3-N0 rectal cancer on rectal MRI were involved in this study. For indistinguishable T2/T3-N0 rectal cancer on rectal MRI, treatment outcomes were not significantly different between surgery-first and nCRT-first strategies.